NCT00476801View on ClinicalTrials.gov

UVA1 Light for Treatment of Scleroderma and Similar Conditions

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
SclerodermaKeloidsOther Fibrosing Conditions
Interventions
DEVICE

German manufactured UVA1 light emitting device

The UVA1 dose will be up to 130 J/cm2.

Trial Locations (1)

48109-0314

University of Michigan Department of Dermatology, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT00476801 - UVA1 Light for Treatment of Scleroderma and Similar Conditions | Biotech Hunter | Biotech Hunter